{
    "root": "b41c9be1-67c2-416e-ae53-5c31eafb8e10",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "vigabatrin",
    "value": "20240327",
    "ingredients": [
        {
            "name": "VIGABATRIN",
            "code": "GR120KRT6K",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63638"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        }
    ],
    "indications": {
        "text": "vigabatrin indicated treatment : refractory complex partial seizures adjunctive therapy patients 2 years age older responded inadequately several alternative treatments ; vigabatrin indicated first line agent ( 1.1 ) infantile spasms -monotherapy infants 1 month 2 years age potential benefits outweigh potential risk vision loss ( 1.2 )",
        "doid_entities": [
            {
                "text": "vision loss (DOID:1432)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1432"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "refractory complex partial seizures adults ( 17 years age older ) : initiate 1,000 mg/day ( 500 mg twice daily ) ; increase total daily dose weekly 500 mg/day increments , recommended dose 3,000 mg/day ( 1,500 mg twice daily ) ( 2.2 ) pediatric ( 2 16 years age ) : recommended based body weight administered two divided doses ( 2.2 ) may increased weekly intervals , depending response ( 2.2 ) dose patients weighing 60 kg according adult recommendations ( 2.2 ) infantile spasms initiate daily dose 50 mg/kg ( 25 mg/kg twice daily ) ; increase total daily dose every 3 days , increments 25 mg/kg/day 50 mg/kg/day , maximum daily dose 150 mg/kg ( 75 mg/kg twice daily ) ( 2.3 ) renal impairment : dose adjustment recommended ( 2.4 , 8.5 , 8.6 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "vigabatrin oral solution usp available 500 mg packets containing white off-white granular powder . supplied follow : ndc 70710-1494-8 carton 50 child-resistant packets oral syringes provided separately pharmacy .",
    "adverseReactions": "none .",
    "indications_original": "Vigabatrin is indicated for the treatment of: Refractory Complex      Partial Seizures as adjunctive therapy in patients 2 years of age and      older who have responded inadequately to several alternative treatments; vigabatrin is not indicated as a first line agent ( 1.1 ) Infantile Spasms      -monotherapy in infants 1 month to 2 years of age for whom the potential      benefits outweigh the potential risk of vision loss ( 1.2 )",
    "contraindications_original": "Refractory Complex Partial Seizures Adults (17 years of      age and older): Initiate at 1,000 mg/day (500 mg twice daily); increase      total daily dose weekly in 500 mg/day increments, to the recommended dose      of 3,000 mg/day (1,500 mg twice daily) ( 2.2 ) Pediatric (2 to 16      years of age): The recommended dosage is based on body weight and      administered as two divided doses ( 2.2 ) The dosage may be      increased in weekly intervals, depending on response ( 2.2 ) Dose patients weighing      more than 60 kg according to adult recommendations ( 2.2 ) Infantile Spasms Initiate at a daily      dose of 50 mg/kg (25 mg/kg twice daily); increase total daily dose every 3      days, in increments of 25 mg/kg/day to 50 mg/kg/day, up to a maximum daily      dose of 150 mg/kg (75 mg/kg twice daily) ( 2.3 ) Renal Impairment : Dose adjustment recommended ( 2.4 , 8.5 , 8.6 )",
    "warningsAndPrecautions_original": "Vigabatrin for oral solution USP is available as 500 mg packets containing a white to off-white granular powder. They are supplied as follow:\n                        NDC 70710-1494-8 in carton of 50 child-resistant packets\n                        The oral syringes are provided separately by the pharmacy.",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "vigabatrin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_63638"
        }
    ]
}